Two-year interim safety and efficacy of pegvaliase in Japanese adults with phenylketonuria

This publication has 20 references indexed in Scilit:

• Adherence to clinic recommendations among patients with phenylketonuria in the United States
  Molecular Genetics and Metabolism, 2017
• Single-dose, subcutaneous recombinant phenylalanine ammonia lyase conjugated with polyethylene glycol in adult patients with phenylketonuria: an open-label, multicentre, phase 1 dose-escalation trial
  The Lancet, 2014
• Phenylalanine hydroxylase deficiency: diagnosis and management guideline
  Genetics in Medicine, 2014
• High phenylalanine levels directly affect mood and sustained attention in adults with phenylketonuria: a randomised, double‐blind, placebo‐controlled, crossover trial
  Journal of Inherited Metabolic Disease, 2010
• Efficacy of Sapropterin Dihydrochloride in Increasing Phenylalanine Tolerance in Children with Phenylketonuria: A Phase III, Randomized, Double-Blind, Placebo-Controlled Study
  The Journal of Pediatrics, 2009
• The response of patients with phenylketonuria and elevated serum phenylalanine to treatment with oral sapropterin dihydrochloride (6R‐tetrahydrobiopterin): a phase II, multicentre, open‐label, screening study
  Journal of Inherited Metabolic Disease, 2007
• Meta-Analysis of Neuropsychological Symptoms of Adolescents and Adults with PKU
  Neuropsychology Review, 2007
• A different approach to treatment of phenylketonuria: Phenylalanine degradation with recombinant phenylalanine ammonia lyase
  Proceedings of the National Academy of Sciences, 1999
• Psychiatric Disorders in Adult Patients With Early-treated Phenylketonuria
  Pediatrics, 1997
• Review of neuropsychological functioning in treated phenylketonuria: an information processing approach
  Acta Paediatrica, 1994